142,000 participants!
The largest randomized trial of a multi-cancer early detection (MCED) test failed its primary endpoint https://
genomeweb.com/cancer/grail-f
da-plans-undeterred-after-nhs-galleri-mced-trial-misses-primary-endpoint
…
Had the enrollment been risk-based instead of age 50, it would likely have been very positive.

→ View original post on X — @erictopol